5-fluorouracil,Leucovorin,Oxaliplatin,Nab-paclitaxel,Gemcitabine
Ipsen
['paclitaxel', 'gi ', ' gem ', 'gemcitabine']
napoli -3 trial : - 18 months os and pfs favor nalirifox over gem + nab-p
- sensitivity analysis (itt population) with data censored at initiation of subsequent anti-cancer therapy confirmed the role of 1st line regimen on improving os. 
MD, Medical Oncology Resident at @HUG